InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ACADIA PHARMACEUTICALS INC

ACAD Clue Score67
United States Fiscal year ends December CIK 0001070494
$19.78 +1.02% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $19.78 +13.68% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue17.3Operating income−272.8Net income−271.4Fiscal year 2017Revenue124.9 +620.7%Operating income−292.4Net income−289.4Fiscal year 2018Revenue223.8 +79.2%Operating income−247.4Net income−245.2Fiscal year 2019Revenue339.1 +51.5%Operating income−246.5Net income−235.3Fiscal year 2020Revenue441.8 +30.3%Operating income−286.6Net income−281.6EPS, diluted−1.79Fiscal year 2021Revenue484.1 +9.6%Operating income−170.4Net income−167.9EPS, diluted−1.05Fiscal year 2022Revenue517.2 +6.8%Operating income−223.6Net income−216.0EPS, diluted−1.34Fiscal year 2023Revenue726.4 +40.4%Operating income−73.4Net income−61.3EPS, diluted−0.37Fiscal year 2024Revenue957.8 +31.8%Operating income230.8Net income226.5EPS, diluted1.36Fiscal year 2025Revenue1,071.5 +11.9%Operating income104.8Net income391.0 +72.7%EPS, diluted2.30
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 17.3 124.9 223.8 339.1 441.8 484.1 517.2 726.4 957.8 1,071.5
Growth +620.7% +79.2% +51.5% +30.3% +9.6% +6.8% +40.4% +31.8% +11.9%
Operating income −272.8 −292.4 −247.4 −246.5 −286.6 −170.4 −223.6 −73.4 230.8 104.8
Net income −271.4 −289.4 −245.2 −235.3 −281.6 −167.9 −216.0 −61.3 226.5 391.0
Growth +72.7%
EPS, diluted n/a n/a n/a n/a −1.79 −1.05 −1.34 −0.37 1.36 2.30

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin82.2%Operating margin−1,574.1%Net margin−1,565.9%Free cash flow margin−1,211.2%Fiscal year 2017Gross margin92.7%Operating margin−234.1%Net margin−231.7%Free cash flow margin−175.0%Fiscal year 2018Gross margin94.5%Operating margin−110.6%Net margin−109.6%Free cash flow margin−75.8%Fiscal year 2019Gross margin96.7%Operating margin−72.7%Net margin−69.4%Free cash flow margin−44.9%Fiscal year 2020Gross margin97.7%Operating margin−64.9%Net margin−63.7%Free cash flow margin−32.5%Fiscal year 2021Gross margin97.8%Operating margin−35.2%Net margin−34.7%Free cash flow margin−26.2%Fiscal year 2022Gross margin98.0%Operating margin−43.2%Net margin−41.8%Free cash flow margin−22.0%Fiscal year 2023Gross margin94.3%Operating margin−10.1%Net margin−8.4%Free cash flow margin2.3%Fiscal year 2024Operating margin24.1%Net margin23.6%Free cash flow margin16.4%Fiscal year 2025Operating margin9.8%Net margin36.5%Free cash flow margin9.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 82.2% 92.7% 94.5% 96.7% 97.7% 97.8% 98.0% 94.3% n/a n/a
Operating margin −1,574.1% −234.1% −110.6% −72.7% −64.9% −35.2% −43.2% −10.1% 24.1% 9.8%
Net margin −1,565.9% −231.7% −109.6% −69.4% −63.7% −34.7% −41.8% −8.4% 23.6% 36.5%
Free cash flow margin −1,211.2% −175.0% −75.8% −44.9% −32.5% −26.2% −22.0% 2.3% 16.4% 9.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−208.4Capital expenditure−1.5Free cash flow−209.9Fiscal year 2017Operating cash flow−217.8Capital expenditure−0.8Free cash flow−218.6Fiscal year 2018Operating cash flow−167.5Capital expenditure−2.1Free cash flow−169.6Fiscal year 2019Operating cash flow−151.1Capital expenditure−1.1Free cash flow−152.3Fiscal year 2020Operating cash flow−136.2Capital expenditure−7.6Free cash flow−143.8Fiscal year 2021Operating cash flow−125.7Capital expenditure−1.1Free cash flow−126.8Fiscal year 2022Operating cash flow−114.0Capital expenditure0.0Free cash flow−114.0Fiscal year 2023Operating cash flow16.7Capital expenditure−0.1Free cash flow16.7Fiscal year 2024Operating cash flow157.7Capital expenditure−0.5Free cash flow157.2 +844.0%Fiscal year 2025Operating cash flow109.8Capital expenditure−4.7Free cash flow105.1 −33.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −208.4 −217.8 −167.5 −151.1 −136.2 −125.7 −114.0 16.7 157.7 109.8
Capital expenditure −1.5 −0.8 −2.1 −1.1 −7.6 −1.1 0.0 −0.1 −0.5 −4.7
Free cash flow −209.9 −218.6 −169.6 −152.3 −143.8 −126.8 −114.0 16.7 157.2 105.1
Growth +844.0% −33.1%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash163.6Shareholders’ equity518.4Fiscal year 2017Cash69.4Shareholders’ equity335.3Fiscal year 2018Cash134.8Shareholders’ equity479.1Fiscal year 2019Cash189.7Shareholders’ equity699.1Fiscal year 2020Cash326.0Shareholders’ equity627.0Fiscal year 2021Cash147.4Shareholders’ equity540.9Fiscal year 2022Cash114.8Shareholders’ equity400.4Fiscal year 2023Cash188.7Shareholders’ equity431.8Fiscal year 2024Cash319.6Shareholders’ equity732.8Fiscal year 2025Cash177.7Shareholders’ equity1,227.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 163.6 69.4 134.8 189.7 326.0 147.4 114.8 188.7 319.6 177.7
Shareholders’ equity 518.4 335.3 479.1 699.1 627.0 540.9 400.4 431.8 732.8 1,227.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
163.6 69.4 134.8 189.7 326.0 147.4 114.8 188.7 319.6 177.7
5.9 17.3 26.1 35.8 48.2 64.4 62.2 98.3 98.7 121.5
4.2 5.2 4.1 6.3 9.7 14.1 11.6 40.4 91.7 111.4
3.1 2.7 3.3 3.2 9.2 8.0 6.0 4.6 4.2 7.5
561.2 384.5 540.2 783.2 782.6 700.1 587.8 749.0 1,187.8 1,564.2
Growth −31.5% +40.5% +45.0% −0.1% −10.5% −16.0% +27.4% +58.6% +31.7%
Liabilities
42.7 49.2 61.1 84.0 155.6 159.2 187.4 317.2 455.0 336.8
Equity
−934.0 −1,223.7 −1,468.9 −1,704.1 −1,985.7 −2,153.6 −2,369.6 −2,430.8 −2,204.4 −1,813.4
518.4 335.3 479.1 699.1 627.0 540.9 400.4 431.8 732.8 1,227.4
Growth −35.3% +42.9% +45.9% −10.3% −13.7% −26.0% +7.8% +69.7% +67.5%
Per share and net cash
121.4 124.4 143.9 155.3 159.6 161.0 162.1 164.7 166.7 170.3
calc 4.27 2.69 3.33 4.50 3.93 3.36 2.47 2.62 4.40 7.21

† The diluted share count jumps at 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.